Skip to main content

Blackstone Group Inc.

SEC CIK
0001393818
Latest filing
Aug 14, 2026

ARQT holding history

Arcutis Biotherapeutics, Inc. in every 13F filed by Blackstone Group Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARQT overviewAll 13F holders of ARQTFull Q2 2026 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
15
Since Q3 2021
Holdings of ARQT by Blackstone Group Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−24,144−100.0%Sold outHolders
Q1 202524,144$377.6K<0.1%00.0%UnchangedHolders
Q4 202424,144$336.3K<0.1%00.0%UnchangedHolders
Q3 202424,144$224.5K<0.1%00.0%UnchangedHolders
Q2 202424,144$224.5K<0.1%00.0%UnchangedHolders
Q1 202424,144$239.3K<0.1%00.0%UnchangedHolders
Q4 202324,144$78.0K<0.1%00.0%UnchangedHolders
Q3 202324,144$128.2K<0.1%00.0%UnchangedHolders
Q2 202324,144$230.1K<0.1%00.0%UnchangedHolders
Q1 202324,144$265.6K<0.1%00.0%UnchangedHolders
Q4 202224,144$357.3K<0.1%00.0%UnchangedHolders
Q3 202224,144$461.0K<0.1%00.0%UnchangedHolders
Q2 202224,144$515.0K<0.1%00.0%UnchangedHolders
Q1 202224,144$465.0K<0.1%00.0%UnchangedHolders
Q4 202124,144$501.0K<0.1%00.0%UnchangedHolders
Q3 202124,144$577.0K<0.1%+24,144NewHolders